Fosun Pharma USA Inc.
SEC CIK 2071437 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NATR | NATURES SUNSHINE PRODUCTS INC | 10% | 0 | — | $32.71M | 1 | 2025-06-27 | 2025-06-27 |
Most active insiders at NATR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% | $2.61M | — |
| 2 | Norman Daniel C | EVP, Pres, Asia | — | $759.4K |
| 3 | Yates Bryant J | EVP, Pres, Europe | — | $751.3K |
| 4 | Brower Nathan G | EVP, GC | — | $341.5K |
| 5 | Lanoy Jonathan David | SVP, CAO | — | $201.1K |
| 6 | Herbert Kevin R. | EVP, Pres, North America | — | $41.4K |
| 7 | Perkins Ruth Ann | EVP, CFO | — | — |
| 8 | Fuller Kevin Gregory | Gbl CMO | — | — |
| 9 | Jones Leslie Shane | EVP, CFO | — | — |
| 10 | Yang Rong | Dir | — | — |
Fosun Pharma USA Inc. made no open-market trades at NATR in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-27 | 2025-06-27 | NATR | NATURES SUNSHINE PRODUCTS INC | Fosun Pharma USA Inc. | 10% | S - Sale | $11.46 | -2.85M | 0 | -100% | -$32.71M |
Purchase Sale Sale after option exercise All abbreviations